학술논문

Hyperfractionated or accelerated hyperfractionated re-irradiation with ≥42 Gy in combination with paclitaxel for secondary/recurrent head-and-neck cancer
Document Type
Article
Source
In: Anticancer Research. (Anticancer Research, June 2018, 38(6):3653-3656)
Subject
Language
English
ISSN
17917530
02507005